Novavax Reports Fourth Quarter and Year-End 2016 Financial Results

Go back to Novavax Reports Fourth Quarter and Year-End 2016 Financial Results

Novavax (NVAX) Tops Q4 EPS by 2c

February 27, 2017 4:10 PM EST

Novavax (NASDAQ: NVAX) reported Q4 EPS of ($0.21), $0.02 better than the analyst estimate of ($0.23). Revenue for the quarter came in at $5.4 million versus the consensus estimate of $5.45 million.

As of December 30, 2016, the company had $235.5 million in cash and cash equivalents and marketable securities compared to... More